

Security policy (edit with Customer reassurance module)
Delivery policy (edit with Customer reassurance module)
Return policy (edit with Customer reassurance module)
Lisinoton H /Lisinoton H
Composition and release form
Lisinoton N - tablets:
1 tab. (10 mg + 12.5 mg) contains lisinopril dihydrate 10.89 mg (equivalent to lisinopril anhydrous 10 mg), hydrochlorothiazide 12.5 mg, excipients: mannitol; Calcium hydrogen phosphate dihydrate; pregelatinized corn starch; iron oxide yellow (E172); iron oxide red (E172); croscarmellose sodium; Magnesium stearate; in packing of 28 pieces;
1 tab. (20 mg + 12.5 mg) contains lisinopril dihydrate 21.78 mg (equivalent to lisinopril anhydrous 20 mg), hydrochlorothiazide 12.5 mg, excipients: mannitol; calcium hydrogen phosphate dihydrate; pregelatinized corn starch; croscarmellose sodium; magnesium stearate; in packing of 28 pieces.
pharmachologic effect
Lisinoton N has a hypotensive, diuretic effect.
Indications
Arterial hypertension (in patients for whom combination therapy is indicated).
Contraindications
Hypersensitivity to lizinotonu N, other ACE inhibitors and derivatives of sulfonamides;
anuria;
severe renal failure (Cl creatinine